113 related articles for article (PubMed ID: 15735925)
1. Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas.
Ribom D; Schoenmaekers M; Engler H; Smits A
J Neurooncol; 2005 Feb; 71(3):325-32. PubMed ID: 15735925
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of PET using 11C-methionine in patients with untreated cerebral gliomas].
Svortsova TIu; Brodskaia ZL; Gurchin AF; Gaĭdaenko KP
Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(4):10-6; discussion 16. PubMed ID: 22379848
[TBL] [Abstract][Full Text] [Related]
3. Clinical interpretation of residual uptake in 11C-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases.
Fukuoka K; Yanagisawa T; Watanabe Y; Suzuki T; Matsutani M; Kuji I; Nishikawa R
J Neurosurg Pediatr; 2015 Oct; 16(4):367-71. PubMed ID: 26140394
[TBL] [Abstract][Full Text] [Related]
4. Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.
Ribom D; Engler H; Blomquist E; Smits A
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):632-40. PubMed ID: 11976801
[TBL] [Abstract][Full Text] [Related]
5. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T
AJNR Am J Neuroradiol; 2008 Jun; 29(6):1176-82. PubMed ID: 18388218
[TBL] [Abstract][Full Text] [Related]
6. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329
[TBL] [Abstract][Full Text] [Related]
8. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.
Pirotte BJ; Levivier M; Goldman S; Massager N; Wikler D; Dewitte O; Bruneau M; Rorive S; David P; Brotchi J
Neurosurgery; 2009 Mar; 64(3):471-81; discussion 481. PubMed ID: 19240609
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
12. Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas.
Galldiks N; Kracht LW; Burghaus L; Thomas A; Jacobs AH; Heiss WD; Herholz K
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):516-24. PubMed ID: 16450140
[TBL] [Abstract][Full Text] [Related]
13. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
14. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
15. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
16. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.
Watanabe A; Muragaki Y; Maruyama T; Shinoda J; Okada Y
J Neurooncol; 2016 Feb; 126(3):577-83. PubMed ID: 26612734
[TBL] [Abstract][Full Text] [Related]
18. Imaging of non- or very subtle contrast-enhancing malignant gliomas with [¹¹C]-methionine positron emission tomography.
Galldiks N; Kracht LW; Dunkl V; Ullrich RT; Vollmar S; Jacobs AH; Fink GR; Schroeter M
Mol Imaging; 2011 Dec; 10(6):453-9. PubMed ID: 22201536
[TBL] [Abstract][Full Text] [Related]
19. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
[TBL] [Abstract][Full Text] [Related]
20. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
